Duodenal exclusion devices: Promising tools in treating obesity and type 2 diabetes

Gut

Volumn 63, Issue 8, 2014, Pages 1201-1202

  Cummings, Bethany P ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CELL NUCLEUS RECEPTOR; FAT; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; LIPID; PROTEIN FXR; PROTEIN TGR5; UNCLASSIFIED DRUG;

BARIATRIC SURGERY; BODY WEIGHT; DUODENAL ENDOLUMINAL SLEEVE SURGERY; ENERGY EXPENDITURE; ENTEROPATHY; FAT MASS; FOOD INTAKE; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HYPERPLASIA; HYPERTROPHY; ILEAL INTERPOSITION; INSULIN RELEASE; INTESTINE HYPERPLASIA; INTESTINE HYPERTROPHY; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; OBESITY; ORGAN SIZE; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; SMALL INTESTINE; WEIGHT REDUCTION;

ANIMALS; BLOOD GLUCOSE; DUODENUM; INTESTINAL ABSORPTION; MALE; METABOLIC SYNDROME X; PROSTHESES AND IMPLANTS;

EID: 84904069817     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-306040     Document Type: Note

References (10)

1. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011;378:31-40.
2. Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: A systematic literature review. Diabetes Metab Syndr Obes 2013;6:327-38.
3. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta- Analysis. Am J Med 2009;122:248-56.
4. Dixon JB, le Roux CW, Rubino F, et al. Bariatric surgery for type 2 diabetes. Lancet 2012;379:2300-11.
5. Patel SR, Hakim D, Mason J, et al. The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes. Surg Obes Relat Dis 2013;9:482-4.
6. Habegger KM, Al-Massadi O, Heppner KM, et al. Duodenal nutrient exclusion improves metabolic syndrome and stimulates villus hyperplasia. Gut 2014;63:1238-46.
7. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007;132:2131-57. (Pubitemid 46711096)
8. Wilson-Perez HE, Chambers AP, Ryan KK, et al. Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency. Diabetes 2013;62:2380-5.
9. Thomas C, Pellicciari R, Pruzanski M, et al. Targeting bile- Acid signalling for metabolic diseases. Nat Rev Drug Discov 2008;7:678-93.
10. Saeidi N, Meoli L, Nestoridi E, et al. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science 2013;341:406-10.